37 results
8-K
EX-99.1
SYRS
Syros Pharmaceuticals Inc.
16 Sep 22
Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement
4:15pm
As previously announced, the Syros leadership team will continue leading the combined company, with Nancy Simonian, M.D., serving as Chief Executive … , LLC and Chairman of Thayer Leadership. Mr. Tyson previously held executive level positions at various pharmaceutical companies, including serving
8-K
EX-99.1
SYRS
Syros Pharmaceuticals Inc.
24 Apr 19
Regulation FD Disclosure
8:31am
Multiple data readouts in 2019 and 2020 Experienced leadership team
98% Previously unexplored regulatory regions of the genome control the expression … of treatment and emerging patient populations Syros is building on its CDK7 leadership with SY-5609, a highly selective oral CDK7 inhibitor, that together with SY-1365 could make for a powerful CDK7 franchise
8-K
EX-99.1
SYRS
Syros Pharmaceuticals Inc.
6 Jul 22
Other Events
4:27pm
control discovery engine has produced a broad and growing pipeline, fueling our leadership in small molecule inhibitors of gene control targets … under the ticker symbol S-Y-R-S and will be led by the existing Syros leadership team. We will also continue TYME’s work on evaluating the best path
8-K
1i4c77kne91 l4l
9 Sep 20
Departure of Directors or Certain Officers
8:30am
8-K
dfd03na
12 Jun 19
Departure of Directors or Certain Officers
4:01pm
8-K
EX-99.1
7cwd wzys6sf8gte3q37
11 Jan 21
Syros Announces Strategic Priorities and Expected Milestones
7:53am
8-K
EX-99.1
fxeyn2 og8gn1
26 May 21
Regulation FD Disclosure
8:30am
8-K
EX-99.1
xh7yzsshe4n47kg1 1a9
25 Feb 21
Regulation FD Disclosure
7:01am
8-K
EX-99.2
c4602
15 Nov 18
Regulation FD Disclosure
4:03pm
8-K
EX-99.1
r5bop7n sejgd4oh
8 Jan 24
Regulation FD Disclosure
7:06am
8-K
EX-99.1
ldgjlvw61xm653a02zck
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-99.1
r21g1efp
5 Jul 22
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
7:07am
PRE 14A
nx15ydwycjjfsyknk3i
12 Apr 24
Preliminary proxy
4:30pm